載入...
Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience
Idiopathic pulmonary fibrosis (IPF) is a fibrotic interstitial lung disease associated with significant morbidity and mortality. Previously, IPF has been managed using immunosuppressive therapy; however, it has been shown that this is associated with increased mortality. In the last 5 years, two dis...
Na minha lista:
| 發表在: | Ther Adv Respir Dis |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6156214/ https://ncbi.nlm.nih.gov/pubmed/30249169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466618800618 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|